Prevalence of deleterious mutations among patients with breast cancer referred for multigene panel testing in a Romanian population.

about

Prevalence of deleterious mutations among patients with breast cancer referred for multigene panel testing in a Romanian population.

Item

http://www.wikidata.org/entity/Q55280273

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Prevalence of deleterious muta ...... ting in a Romanian population.

@en

Prevalence of deleterious muta ...... ting in a Romanian population.

@nl

type

Item

label

Prevalence of deleterious muta ...... ting in a Romanian population.

@en

Prevalence of deleterious muta ...... ting in a Romanian population.

@nl

prefLabel

Prevalence of deleterious muta ...... ting in a Romanian population.

@en

Prevalence of deleterious muta ...... ting in a Romanian population.

@nl

P1476

Prevalence of deleterious muta ...... ting in a Romanian population.

@en

P2093

Dan Tudor Eniu

http://www.w3.org/2001/XMLSchema#string

Florin Vasile Stamatian

http://www.w3.org/2001/XMLSchema#string

Gabriela Caracostea

http://www.w3.org/2001/XMLSchema#string

Iulian Gabriel Goidescu

http://www.w3.org/2001/XMLSchema#string

P2860

Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing

A new paradigm of genetic testing for hereditary breast/ovarian cancers

Clinical and molecular characterization of the BRCA2 p.Asn3124Ile variant reveals substantial evidence for pathogenic significance.

Rare germline mutations in PALB2 and breast cancer risk: a population-based study.

Five recurrent BRCA1/2 mutations are responsible for cancer predisposition in the majority of Slovenian breast cancer families.

The occurrence of germline BRCA1 and BRCA2 sequence alterations in Slovenian population.

BRCA1 mutations in women with familial or early-onset breast cancer and BRCA2 mutations in familial cancer in Estonia.

Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary.

Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes.

Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients

P304

157-165

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.15386/CJMED-894

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-04-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29785153

http://www.w3.org/2001/XMLSchema#string

P932

5958980

http://www.w3.org/2001/XMLSchema#string